Labcorp receives fda authorization to make at-home covid-19 collection kits available through retail

Burlington, n.c.--(business wire)--labcorp (nyse: lh), a leading global life sciences company that is focused on advancing health and guiding patient care decisions, today announced that the u.s. food and drug administration (fda) granted emergency use authorization (eua) for the pixel by labcorp™ covid-19 test home collection kit to become the first to be available over the counter without requiring a prescription. the kit is currently available through the pixel by labcorp website, and this a
LH Ratings Summary
LH Quant Ranking